Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury
about
Stem Cell Therapy for Treatment of Ocular DisordersBone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsTapping Stem Cells to Target AMD: Challenges and ProspectsStem cells in retinal regeneration: past, present and futureRegenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathyIntravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degenerationIntravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findingsQuality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injuryCell-based therapy approaches: the hope for incurable diseases.Stem cells in clinical trials for treatment of retinal degeneration.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Advances in bone marrow stem cell therapy for retinal dysfunction.Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection.Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies.Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging.
P2860
Q26746974-C38E35F1-BD6A-40CC-95A3-AFEBEFCFBBE6Q26749552-624A6E2A-D4FA-4F2D-9931-15F99AEE32EEQ26799625-6D1B533D-0453-4CCB-A1F5-E6AE066354F4Q26828014-5CA0CCDD-11BA-41E2-BCF5-26EF369889AFQ27334841-0F0043DE-03E2-4BFC-8D43-5CC9A9BDDCD0Q33739755-A1455205-E03D-4272-81C9-9E6889EC58FCQ34882870-8DA8CDFC-5483-4BFF-A5CD-A11D7C415725Q35368291-DD7B8485-E7FF-4EFE-8FF1-BCD247B74A6DQ36802005-666626D8-FF28-4629-8AF1-367E39503218Q38265206-2C2E9C56-6338-4FF7-A419-BE4376060F21Q38594426-6FAC090C-FBA0-4CE9-B66C-E15F51D602D6Q38767261-DB5AD296-C250-46A3-B9F4-9124DD8299F7Q38804673-C9859336-A34D-4F08-9289-8DC6AAB37EACQ42576282-0E67B2CC-D551-4434-AB5E-AD6CE70443AEQ47093712-CC435DE1-69F9-42F0-9256-C083B2806777Q55262336-1B4F4A46-BBB5-40BF-B897-82DC10C5E9B3
P2860
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@ast
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@en
type
label
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@ast
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@en
prefLabel
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@ast
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@en
P2093
P2860
P356
P1476
Long-term effects of intravitr ...... te ischemia-reperfusion injury
@en
P2093
Bradley Shibata
David G Telander
Gerhard Bauer
Jeannine McGee
Krisztina I Forward
Maria B Grant
Paul G Fitzgerald
Sergio Caballero
P2860
P304
P356
10.1167/IOVS.11-8833
P407
P50
P577
2012-02-23T00:00:00Z